These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 25360704)

  • 1. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.
    Fieblinger T; Graves SM; Sebel LE; Alcacer C; Plotkin JL; Gertler TS; Chan CS; Heiman M; Greengard P; Cenci MA; Surmeier DJ
    Nat Commun; 2014 Oct; 5():5316. PubMed ID: 25360704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
    Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
    J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
    Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
    Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.
    Thiele SL; Chen B; Lo C; Gertler TS; Warre R; Surmeier JD; Brotchie JM; Nash JE
    Neurobiol Dis; 2014 Nov; 71():334-44. PubMed ID: 25171793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's disease.
    Bagetta V; Sgobio C; Pendolino V; Del Papa G; Tozzi A; Ghiglieri V; Giampà C; Zianni E; Gardoni F; Calabresi P; Picconi B
    J Neurosci; 2012 Dec; 32(49):17921-31. PubMed ID: 23223310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP
    J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of GPR88 enhances the locomotor response to L-DOPA in experimental parkinsonism while counteracting the induction of dyskinesia.
    Mantas I; Yang Y; Mannoury-la-Cour C; Millan MJ; Zhang X; Svenningsson P
    Neuropharmacology; 2020 Jan; 162():107829. PubMed ID: 31666199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms.
    Ghiglieri V; Mineo D; Vannelli A; Cacace F; Mancini M; Pendolino V; Napolitano F; di Maio A; Mellone M; Stanic J; Tronci E; Fidalgo C; Stancampiano R; Carta M; Calabresi P; Gardoni F; Usiello A; Picconi B
    Neurobiol Dis; 2016 Feb; 86():140-53. PubMed ID: 26639853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology.
    Mellone M; Zianni E; Stanic J; Campanelli F; Marino G; Ghiglieri V; Longhi A; Thiolat ML; Li Q; Calabresi P; Bezard E; Picconi B; Di Luca M; Gardoni F
    Neurobiol Dis; 2019 Jan; 121():338-349. PubMed ID: 30261285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
    Shen W; Plotkin JL; Francardo V; Ko WK; Xie Z; Li Q; Fieblinger T; Wess J; Neubig RR; Lindsley CW; Conn PJ; Greengard P; Bezard E; Cenci MA; Surmeier DJ
    Neuron; 2015 Nov; 88(4):762-73. PubMed ID: 26590347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity?
    Villalba RM; Smith Y
    J Neural Transm (Vienna); 2018 Mar; 125(3):431-447. PubMed ID: 28540422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
    Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H
    J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia.
    Picconi B; Centonze D; Håkansson K; Bernardi G; Greengard P; Fisone G; Cenci MA; Calabresi P
    Nat Neurosci; 2003 May; 6(5):501-6. PubMed ID: 12665799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise decreases aberrant corticostriatal plasticity in an animal model of l-DOPA-induced dyskinesia.
    Speck AE; Aguiar AS; Ferreira SG; Silva HB; Tomé ÂR; Agostinho P; Cunha RA; Prediger RD
    Am J Physiol Regul Integr Comp Physiol; 2021 Apr; 320(4):R541-R546. PubMed ID: 33533311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing of AMPA receptor subunits in the 6-OHDA-lesioned rat model of Parkinson's disease and L-DOPA-induced dyskinesia.
    Kobylecki C; Crossman AR; Ravenscroft P
    Exp Neurol; 2013 Sep; 247():476-84. PubMed ID: 23360800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
    Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD.
    Picconi B; Ghiglieri V; Bagetta V; Barone I; Sgobio C; Calabresi P
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S145-9. PubMed ID: 18583173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.